BSECompany Update4d ago · 15 Aug 2026, 06:48 pm
Newspaper Advertisement regarding the 48th Annual General Meeting ("AGM") to be held on Friday, September 11, 2026 at 2.00 p.m. through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM")
Glenmark Pharmaceuticals Ltd · 532296
✦ AI Summary
Glenmark Pharmaceuticals Ltd has announced that its 48th Annual General Meeting will be held on September 11, 2026, through video conferencing or other audio-visual means.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
98da0bf3-657b-4248-abcd-a617ae84de93.pdf
View document text
August 15, 2026
To, To,
National Stock Exchange of India Limited, BSE Limited,
“Exchange Plaza”, Corporate Relationship Department,
5th Floor, Plot No. C/1, G Block, 2nd Floor, New Trading Ring,
Bandra- Kurla Complex, Bandra (East), P.J. Towers, Dalal Street,
Mumbai – 400 051 Mumbai – 400 001
Scrip Name: GLENMARK Scrip Code: 532296
ISIN: INE935A01035 ISIN: INE935A01035
Our Reference No. 50/26-27 Our Reference No. 50/26-27
Dear Sir/ Madam,
Sub: Newspaper Advertisement regarding the 48th Annual General Meeting (“the AGM”) to be
held on Friday, September 11, 2026 at 2.00 p.m. through Video Conferencing (“VC”)/ Other
Audio-Visual Means (“OAVM”)
Pursuant to the provisions of the Companies Act, 2013, the applicable Rules made thereunder,
the General Circular No. 03/2025 dated September 22, 2025 (hereinafter referred to as “Circular”)
issued by the Ministry of Corporate Affairs (“MCA”) and the applicable provisions of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has made a
public notice informing about 48th Annual General Meeting of the Company through Video
Conferencing (“VC”)/ Other Audio-Visual Means (“OAVM”) scheduled to be held on Friday,
September 11, 2026 at 2.00 p.m.
We hereby submit the copies of the public notice published in English daily “Financial Express”
and Marathi daily “Loksatta” – All Editions, on Saturday, August 15, 2026, for your information
and the same is also uploaded on the website of the Company at https://glenmarkpharma.com/
You are requested to take the above on record.
Thanking you.
Yours faithfully,
For Glenmark Pharmaceuticals Limited
Rashmi Khandelwal
Company Secretary & Compliance Officer
ACS – 28839
Encl: As above
Glenmark Pharmaceuticals Limited
Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099
T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com
Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com